Rojin G. Raj1, Janet Benny1, Abubaker Siddiq2*, Shethal Saji1, Sreelakshmi P.1
1Department of Pharmacy Practice, SJM College of Pharmacy, Chitradurga- 577502, Karnataka, India
2Department of Pharmacology, SJM College of Pharmacy, Chitradurga – 577502, Karnataka, India
*Address for Corresponding Author
Dr. Abubaker Siddiq
Associate Professor
SJM College of Pharmacy, SJM Campus, Chitradurga, Karnataka, India
Abstract
Background: Type 2 diabetes mellitus is a disease whose prevalance is projected to rise from the current estimated 240 million affected (6% of adults) 2017 to 380 million (7%) by 2025. Drug prescribing studies can identify irrational prescribing pattern and can suggest modification in the current prescribing practices. Objective: The objective of the present work was to evaluate the anti-diabetic medication usage among geriatric and non-geriatric population, to assess and compare the pharmaceutical care issues like drug –drug interaction, contraindications of therapy and drug duplication, to assess and compare the associated comorbidities and complications of type II diabetes mellitus. Materials and Methods: A prospective observative study was conducted in a teaching hospital. A total of 150 geriatric and non geriatric patients with type 2 DM were enrolled and studied for 6 months. Results: The study found out that Insulin was most prescribed drug followed by dual therapy of oral hypoglycemic agents and metformin was the most frequently prescribed drug in monotherapy. Comorbidities and diabetic complications were more in geriatric patients thus the drug related problems were also more in them. Conclusion: Comorbid conditions, complications and pharmaceutical care issues were seen more in geriatric patients when compared to non geriatrics.Insulin therapy was given highest in geriatrics and oral hypoglycemic agents was given highest in non geriatrics.
Keywords: Diabetes mellitus, complications, comorbidities, anti-diabetic medications